Status:

TERMINATED

Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode

Lead Sponsor:

McMaster University

Conditions:

Shoulder Dislocation

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

Each year within Canada and the US, more than 30,000 children and adolescents will have an injury to their shoulder resulting in a shoulder dislocation. Although the current practice is to manage this...

Eligibility Criteria

Inclusion

  • Males and females between the ages of 12 and 18, inclusive
  • Patients with a first-time traumatic anterior glenohumeral dislocation within the past 3 months
  • Anterior glenohumeral dislocation confirmed by radiography, reduction required by medical personnel, or demonstration of anterior apprehension on physical examination following injury to the shoulder
  • MRI or MRA demonstrating disruption of the glenohumeral soft tissues (including the labrum, periosteum, or inferior glenohumeral ligament) relating to instability
  • Patients who have the ability to speak, understand, and read English
  • Provision of informed consent (age 18) or parental consent (ages 12-17, inclusive)
  • Provision of informed child assent (ages 12-17, inclusive)

Exclusion

  • Previous dislocation episodes or instability of the affected shoulder
  • Previous surgeries involving the affected shoulder
  • History or clinical exam findings of generalized ligamentous laxity (defined as a Beighton score of 4 or more points)
  • History of multi-directional instability of either shoulder
  • Concomitant fracture of the tuberosity, humerus, or glenoid (excluding a Bankart or Hill Sachs lesion)
  • Bony Bankart lesion exceeding 15% of the glenoid surface (using the best-fit circle method on MRI)
  • Hill Sachs lesion exceeding 15% of the humeral diameter (Measured on transaxial slice of MRI similar to Salomonsson et al.)
  • A neurological injury of the affected arm
  • Patients who will likely have problems, in the judgement of the investigator, with maintaining follow-up
  • Any other reason(s) the investigator feels is relevant for excluding the patient

Key Trial Info

Start Date :

September 19 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 24 2025

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT04887337

Start Date

September 19 2022

End Date

October 24 2025

Last Update

November 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McMaster University

Hamilton, Ontario, Canada, L8N 3Z5